COMMUNITY

Medicare drug costs should parallel those of MedicaidMedicare should have the same authority that Medicaid has to negotiate drug prices directly with manufacturers. If the government can do it for one program, it can do it for another.
Point-of-care testing opens door to new patient-care modelCLIA-waived tests may be the next big thing.
Quit stigmatizing naloxoneEpinephrine saves lives. So does naloxone. Why are they regarded differently?
Pharmacists should get training in naloxone use nowPharmacists are the most accessible healthcare resource. Once trained in naloxone use, we can train our patients in all aspects of opioid use. This will make a difference.
Solutions to the ongoing opioid epidemic take shape"Naloxone should be the fire extinguisher in the home of everyone who is at risk."
Pharmacy’s Catch-22: Save a life — or save your livelihood?When a snap decision is called for, “What is our corporate loss-prevention policy?” can compete in an employee’s brain with “What is the best thing for the patient?”
Campaign targets illegal online pharmaciesA new campaign is warning seniors about the risk of buying drugs from illegal online pharmacies.
Synchronized meds boost patient adherence, pharmacy efficiencyWith the industry changing from a pill-centered model to a patient-centered model, med sync becomes more important than ever.
Opioid use for chronic pain: The debate goes onA champion of pain patients and a proponent of limited opioid access talk about the issues in a genial debate.
Pharmacists take aim at med errors during care transitionsHealthcare has changed, and the emphasis on transitions of care has grown as inpatient and outpatient services are linking up.

Poll